Virax Biolabs Group Limited Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
UBS GROUP AG | 02/14/2025 | 37,915 | $85,309 | 84.68% | 1.89% |
XTX TOPCO LTD | 02/13/2025 | 11,863 | $26,692 | 100.00% | 0.59% |
ROYAL BANK OF CANADA | 02/14/2025 | 10,400 | $23,000 | 100.00% | 0.52% |
01/23/2025 | 2,700 | $6,075 | 100.00% | 0.13% | |
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 02/11/2025 | 20 | $45 | 100.00% | 0.00% |
TOWER RESEARCH CAPITAL LLC (TRC) | 02/13/2025 | 9 | $20 | 100.00% | 0.00% |
RENAISSANCE TECHNOLOGIES LLC | 02/13/2025 | 0 | $0 | -100.00% | 0.00% |
HEADLANDS TECHNOLOGIES LLC | 02/12/2025 | 0 | $0 | -100.00% | 0.00% |
JANE STREET GROUP, LLC | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
SQUAREPOINT OPS LLC | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
Virax Biolabs Group Limited institutional Ownership - FAQ's
During the previous two years, 9 institutional investors and hedge funds held shares of Virax Biolabs Group Limited. The most heavily invested institutionals were:
UBS Group AG: 37,915
XTX Topco Ltd: 11,863
ROYAL BANK OF CANADA: 10,400
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO: 20
Tower Research Capital LLC (TRC): 9
RENAISSANCE TECHNOLOGIES LLC: 0
3.14% of Virax Biolabs Group Limited stock is owned by institutional investors.
Institutional investors have bought a total of 60,207 shares in the last 24 months. This purchase volume represents approximately $187,244 in transactions.